의료기술 인사이트

The European gynecological device market was negatively impacted by the COVID-19 pandemic. However, the overall market for gynecological devices will grow marginally over the forecast period…

In recent years, the Asia Pacific trauma device market has been negatively impacted by various events, including the COVID-19 pandemic, which diminished procedure volumes at the time, as well as…

Although the global COVID-19 pandemic negatively impacted the Asia Pacific IC market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term…

The European EP mapping and ablation device market will experience moderate growth through 2032 due to increasing ablation procedure volumes, technological advancements, and the uptake of premium…

The Asia Pacific neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing…

The European trauma device market was negatively impacted by the COVID-19 pandemic to some extent, although the urgent nature of many trauma procedures limited the severity of the effect…

The Asia Pacific small-joint reconstructive implant market remains relatively underdeveloped compared to the US and European markets, offering substantial growth potential. The adoption of small-…

The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population…

The European neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data as well as access to the…

The Asia Pacific spinal implant market will continue to experience strong growth throughout the forecast period. The uptake of premium innovations such as 3-D printed implants, nonfusion…

The European reconstructive small-joint market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward,…

The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…